(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Humira: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ADALIMUMAB (a dal AYE mu mab) is used to treat several types of arthritis. It is also used to treat Crohn's disease, ulcerative colitis, and plaque psoriasis.

CVS Pharmacy Patient Statistics for Humira: Solution for injection(10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Humira 10mg/0.2ml Pediatric Pre-Filled Syringe Kit

NDC: 000746347
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Hidradenitis Suppurativa, Psoriasis, Psoriatic Arthritis, Crohn's Disease, Ankylosing Spondylitis, Polyarticular Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Do not use if product has been frozen
Store in carton until time of use
Humira 10mg/0.2ml Pediatric Pre-Filled Syringe Kit

Reported Side Effects for Humira 10mg/0.2ml Pediatric Pre-Filled Syringe Kit

Abnormal Heart Rhythm Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Vomiting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Fainting Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
High Red Blood Cells Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Cramps Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
<78.0%*
Severity: MILD
Onset: DELAYED
Hole In Intestines Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Intestinal Bleeding Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Brain Dysfunction Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Cataracts Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Dead Bone Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Blood Clot Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Joint Inflammation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Brain Bruise Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: RAPID
Pelvic Pain Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
<5.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Muscle Weakness Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Death Of Liver Tissue Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Confusion Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Breathing Difficulties Incidence:
<5.0%*
Severity: SEVERE
Onset: RAPID
Broken Bones Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Bladder Infection Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Dehydration Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Shortness Of Breath Incidence:
<5.0%*
Severity: MODERATE
Onset: EARLY
Throat Inflammation Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Gallstones Incidence:
<5.0%*
Severity: MODERATE
Onset: DELAYED
Cholecystitis Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Suddenly Stopped Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Fluid Around The Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Inflamed Heart Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
No White Blood Cells Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Shaking Incidence:
<5.0%*
Severity: MILD
Onset: EARLY
Irregular Heart Beat Incidence:
<5.0%*
Severity: SEVERE
Onset: EARLY
Fluid Around The Lungs Incidence:
<5.0%*
Severity: SEVERE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
0.9-4.4%*
Severity: MODERATE
Onset: DELAYED
Antibody Formation Incidence:
1.0-26.0%*
Severity: MODERATE
Onset: DELAYED
Anaphylactoid Reactions Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Hives Incidence:
1.0%*
Severity: MILD
Onset: RAPID
Joint Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
5.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
5.0-20.0%*
Severity: MILD
Onset: RAPID
Blood In The Urine Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
High Cholesterol Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Back Pain Incidence:
6.0%*
Severity: MILD
Onset: DELAYED
Flu Incidence:
7.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Fats Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Stomach Pain Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
9.0%*
Severity: MILD
Onset: EARLY
Sinus Infection Incidence:
11.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
12.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
12.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Humira

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.